(Q39674746)

13 September 2017

1 reference

title

Kawasaki disease: clinical perspective (English)

1 reference

13 September 2017

1 reference

Bierman FZ

1

1 reference

13 September 2017

Gersony WM

series ordinal

2

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 November 1987

1 reference

The Journal of Pediatrics

13 September 2017

published in

1 reference

13 September 2017

volume

111

1 reference

13 September 2017

issue

5

1 reference

13 September 2017

page(s)

789-793

1 reference

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980269-X

High-dose intravenous gammaglobulin for Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980269-X

Incomplete Kawasaki disease with coronary artery involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980269-X

Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980269-X

Sensitivity, specificity and predictive value of two-dimensional echocardiography in detecting coronary artery aneurysms in patients with Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980269-X

Clinical spectrum of Kawasaki disease in infants younger than 6 months of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980269-X

Kawasaki disease: review of risk factors for coronary aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980269-X

Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980269-X

Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980269-X

Regression of coronary aneurysms in patients with Kawasaki syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980269-X

Indication of aortocoronary by-pass for coronary arterial obstruction due to Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980269-X

Surgery for coronary heart disease due to mucocutaneous lymph node syndrome (Kawasaki disease). Report of 6 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980269-X

Difficulty in achieving therapeutic serum concentrations of salicylate in Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980269-X

A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980269-X

Inactivation and partition of human T-cell lymphotrophic virus, type III, during ethanol fractionation of plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980269-X

Salicylate Treatment of Epidemic Kawasaki Disease in New York City

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980269-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(87)80269-X

1 reference

13 September 2017

1 reference